Allucent is attending the World Orphan Drug Congress in Boston
Meet Allucent’s dedicated team of rare disease and orphan drug experts at the World Orphan Drug Congress USA and share your passion for bringing innovative medicines and life-saving therapies to patients around the world. Our extensive clinical and consulting experience, combined with a patient-centric approach, can light the way for the most complex rare disease clinical trials and orphan drug development.
Schedule a meeting to discuss current trends in rare diseases with the A-Team.
Speaker:, Marcus S. Delatte, PhD – Vice President, Regulatory Strategy
Session: 14.50 – 15.10 on 23 April (track is Clinical Development & Regulatory)
Title: Regulatory Landscape for Developing Therapeutics for Rare Seizure Disorders
- Types of disorders typically targeted and potential therapeutics
- Examples of regulatory challenges developing products for this patient population (e.g., safety and quality concerns with cannabinoids; leveraging historical controls and natural studies)
- Evidence of efficacy with different types of therapeutics
Fill out the form to schedule a meeting.
Share This
